INVERNIZZI, ELENA
INVERNIZZI, ELENA
Universita' degli Studi di MILANO
Is there an association between inflammatory/anti-oxidant markers and the presence of psychotic symptoms or severity of illness in mood and psychotic disorders? A multi-centric study on a drug-free sample
2022 A. Caldiroli, E. Capuzzi, J. Barkin, S. Grassi, C. Esposito, A. Auxilia, S. Russo, I. Tagliabue, G. Carnevali, F. Mucci, E. Invernizzi, M. Clerici, M. Buoli
Association between the glyco-metabolic adverse effects of antipsychotic drugs and their chemical and pharmacological profile: A network meta-analysis and regression
2021 C. Carnovale, E. Lucenteforte, V. Battini, F. Mazhar, M. Fornili, E. Invernizzi, G. Mosini, M. Gringeri, A. Capuano, C. Scavone, M. Nobile, C. Vantaggiato, S. Pisano, C. Bravaccio, S. Radice, E. Clementi, M. Pozzi
Hyponatremia Following Antipsychotic Treatment: In Silico Pharmacodynamics Analysis of Spontaneous Reports From the US Food and Drug Administration Adverse Event Reporting System Database and an Updated Systematic Review
2021 F. Mazhar, V. Battini, M. Pozzi, E. Invernizzi, G. Mosini, M. Gringeri, A. Capuano, C. Scavone, S. Radice, E. Clementi, C. Carnovale
β-blockers associated hypoglycaemia: new insights from a real-world pharmacovigilance study [Beta-blocker-associated hypoglycaemia: New insights from a real-world pharmacovigilance study]
2021 C. Carnovale, M. Gringeri, V. Battini, G. Mosini, E. Invernizzi, F. Mazhar, F. Bergamaschi, M. Fumagalli, G.V. Zuccotti, E.G.I. Clementi, S. Radice, V. Fabiano